Vitamin Supplementation and a Personalized Diet in Patients with Neuroendocrine Tumors: The DIVIT Study Abstract #2772

Introduction: Patients with neuroendocrine tumors (NETs) are at risk for vitamin deficiencies and poor nutritional status due to excessive serotonin production, diarrhea, previous gastrointestinal surgery, and/or treatment with somatostatin analogues (SSA). Little knowledge exists about vitamin deficiency and how patients should be supported for the deficiencies they develop during their long-lasting disease.
Aim(s): To investigate if adequate vitamin supplementation and optimal personalized dietary consultation improves the proportion of patients with normal vitamin levels
Materials and methods: Patients with metastatic NET that were treated with SSA for > 6 months were enrolled in this single-center, single-arm intervention study. Patients received vitamin A, D, E, K, B12 and/or B3 supplementation when deficient. Furthermore, patients got personal dietary counseling by a dedicated NET dietician during the study period. At baseline, after 4 and 18 weeks blood or urine vitamin levels were measured.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - others, not specified
Presenting Author: MD Johannes Stelwagen

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1884 Towards Optimal Personalized Diet and Vitamin Supplementation in NET Patients; A Feasibility Study
Introduction: Patients with a neuroendocrine tumor (NET) often have gastro-intestinal complaints due to somatostatin analogue (SSA), tumor mass, secretion of neuroendocrine amines or treatment. This can lead to impaired absorption of critical food components such as vitamins. Serotonin producing NET patients may also have low plasma tryptophan.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Medical treatment - Others
Presenting Author: drs Ld de Hosson
#2078 Self-Reported Side Effects in Neuroendocrine Tumor (NET) Patients Prescribed Somatostatin Analogues – The Role for Specialist Dietitians and Nurses
Introduction: In practice, many patients with NETs report a change in symptoms after starting somatostatin analogues (SSA’s). Many health professionals and NET patient advocates have noticed that some of the side effects experienced by patients are more common than patient information literature suggests. It is therefore important to ask what and how severe experiences are, and compare to literature, to help raise awareness amongst NET health professionals.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Tara Whyand
Authors: Whyand T, Davies P, Bouvier C, ...
#2147 Nutritional Assessment and Vitamin Deficiencies in Patients with NETs
Introduction: As a result of disease or related to its management, patients with neuroendocrine tumours may have altered gut or pancreatic function that can cause nutritional deficiencies.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Mark Reynolds
Authors: Lim S, Reynolds M, Rees D A, Chaudhry R, ...
#2806 Sarcopenia: Don't Judge a Book by It's Cover
Introduction: Sarcopenia is characterised by loss of muscle mass and function. We previously reported anthropometrical data for a range of NET diagnoses within 3 months of diagnosis. The majority of NET patients were overweight or obese, however reduced muscle function was observed in over half of patients regardless of BMI and other parameters.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: Tara Whyand
#1289 Reduced 25-OH-Vitamin D Levels in Patients with Chronic Autoimmune Atrophic Gastritis
Introduction: Chronic atrophic autoimmune gastritis (CAAG) is characterized by parietal cells disruption leading to hypochlorhydria and vitamin B12 malabsorption. An increased risk of osteoporosis was reported in patients with long-standing hypochlorhydria. Only few studies reported a possible association between CAAG and 25OHVitamin D (25OHvitD) deficiency.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: dr Sara Massironi
Keywords: vitamin D, CAAG